Autor/es reacciones

Josep Mallolas

Head of the HIV-AIDS unit, Hospital Clínic-Barcelona

The articles are of very good quality. 

All attempts to develop preventive HIV vaccines have failed for decades. These studies provide evidence of new and different strategies to develop broadly neutralising antibodies against HIV. All these studies point to the possibility that they may be an option that could be effective in preventing HIV infection. All these studies represent an exciting proof of concept that needs to be further investigated.  

Of course, there are still limitations. Although the idea is promising, there are no clinical studies to support it. Only one of them has an ongoing phase I clinical trial. The full clinical development to provide safety and efficacy data is therefore lacking.

EN